National Generic Pharmaceuticals – Project Revive
- Buyer
- NHS England
- Value
- £6,864,264
- Closes
- 30 November 2026
- Where
- London, the North East
- Type
- Sets up a framework (suppliers apply to join)
In plain English
NHS England is procuring generic pharmaceuticals, which are standard, non-branded medicines, under a project called Revive. The contract covers three groups of NHS regions and runs for 22 months, from 1 April 2027 to 31 January 2029, with an estimated value of £6,864,264.
What the buyer wants
• Supply generic pharmaceutical products to the DCE/DSW regions from 01/04/27 to 31/01/29. • Supply generic pharmaceutical products to the DLS/DNE regions over the same period. • Supply generic pharmaceutical products to the DLN/DNW regions over the same period.
Requirements
What could rule a small business out: The notice sets out no eligibility criteria, but its value of about £6.9 million over 22 months across three regional groups for supplying medicines would most likely rule out small businesses that cannot supply pharmaceutical products at that scale.
Always check the tender documents.
How to bid
This is a framework: the buyer picks a set of suppliers now and awards work to them over several years. If you are not on it when it is awarded, you usually cannot win work from it until it is re-tendered, so this is the window to bid.
Where to apply
The notice doesn't say where to apply. NHS England uses Atamis for its other tenders, so start there: make a free account, then search for this tender's title.
Questions about this tender? The official notice gives the buyer's contact.
More open tenders from NHS England
- Independent eval. of the NHS solar and battery storage scheme 25/26, NHS England, £95,000, closes 6 November 2026
- Maintenance of the National Competency Framework for Data Professionals, NHS England, £80,000, closes 6 November 2026
- Tech support for the dev. of the PCF requirements of the NHS Supplier Roadmap, NHS England, £96,000, closes 9 November 2026
- National Competency Framework for Data: Adoption, Impact & Evidence Review, NHS England, £95,000, closes 10 November 2026
- Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service, NHS England, £238,608, closes 10 November 2026
Check whether your business could win this, free
Get a plain-English bid plan for this tender with the bid coach